To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension
NCT03021265 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 676
Last updated 2020-05-12
Summary
Study to evaluate real-world safety, effectiveness and appropriate use of Micatrio® Combination Tablets treatment in patients with hypertension
Conditions
Interventions
- DRUG
-
T80/A5/H12.5 FDC
Drug
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
-
Rie Ikeda, +81364172200 · [email protected]
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-01-20
- Primary Completion
- 2019-04-11
- Completion
- 2019-04-11
Countries
- Japan
Study Locations
More Related Trials
-
An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy
NCT01103960 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension
NCT00326768 ·Status: COMPLETED ·Phase: PHASE3
-
26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension
NCT00624052 ·Status: COMPLETED ·Phase: PHASE3
-
Filtered Trial for Amlodipine Non-responder
NCT00558064 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension
NCT01353274 ·Status: COMPLETED
-
Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension
NCT00860262 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
NCT01050062 ·Status: COMPLETED
-
Open Label Study Telmisartan and Amlodipine in Hypertension
NCT00614380 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant Use
NCT02121535 ·Status: COMPLETED ·Phase: PHASE1
-
Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
NCT00553267 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
NCT00558428 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension
NCT00257491 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
NCT00618774 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
NCT00281580 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
NCT00509470 ·Status: COMPLETED ·Phase: PHASE4
-
Telmisartan 80mg Non-responder Trial
NCT01222520 ·Status: COMPLETED ·Phase: PHASE3
-
Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant Use
NCT02129192 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
NCT02183675 ·Status: COMPLETED ·Phase: PHASE1
-
3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
NCT00153049 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy
NCT00144222 ·Status: COMPLETED ·Phase: PHASE3
-
MK-0954E Study in Participants With Hypertension (MK-0954E-357)
NCT01302691 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers
NCT02194309 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice
NCT03205137 ·Status: WITHDRAWN
-
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
NCT00649389 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan, Amlodipine and Combination in Healthy Subjects
NCT01181011 ·Status: COMPLETED ·Phase: PHASE1